INDEMNIFICATION AGREEMENTIndemnification Agreement • June 24th, 2021 • Genelux Corp • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of , by and between GENELUX CORPORATION, a Delaware corporation (the “Company”), and (“Indemnitee”).
LEASE [San Diego Science Center / Genelux Corporation]Lease • June 24th, 2021 • Genelux Corp • Pharmaceutical preparations
GENELUX CORPORATION INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • June 24th, 2021 • Genelux Corp • Pharmaceutical preparations • California
This INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of January 8, 2010 by and among Genelux Corporation, a Delaware corporation (the “Company”), Abbott Laboratories, an Illinois corporation (“Abbott”), and Dr. Szalay (the “Founder”).
INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE—GROSS MODIFIED DATED JULY 2, 2018 BY AND BETWEEN GENELUX CORPORATION, A DELAWARE CORPORATION AND MARINDUSTRY PARTNERS, LP, A CALIFORNIA LIMITED PARTNERSHIPGenelux Corp • June 24th, 2021 • Pharmaceutical preparations
CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • June 24th, 2021 • Genelux Corp • Pharmaceutical preparations • California
This Convertible Note Purchase Agreement (the “Agreement”) is made and entered on this ___th day of _____, 2019, (the “Effective Date”) by and between [name] (“Lender”), and GENELUX CORPORATION, a corporation duly organized and validly existing under the laws of the State of Delaware (“Borrower”).
UMBRELLA AGREEMENT REGARDING _______ FAMILY INVESTMENTS IN GENEUX CORPORATIONUmbrella Agreement • June 24th, 2021 • Genelux Corp • Pharmaceutical preparations
This umbrella agreement (“Agreement”) is entered into this ___ day of ____ between Genelux Corporation, 3030 Bunker Hill Street, #310, San Diego, CA 92109 (hereafter “Company”) and the following individuals and entities (collectively, the “_______”):
GENELUX CORPORATION CONSULTING AGREEMENTGenelux Corporation Consulting Agreement • June 24th, 2021 • Genelux Corp • Pharmaceutical preparations • California
THIS AGREEMENT is made and entered into effective as of the 1st day of September, 2011 (the “Effective Date”), by and between Genelux Corporation, a Delaware corporation (the “Company”), and Pharmaceutical Research Consulting (PRC) (“Consultant”).
Agreement/Promissory NoteAgreement • June 24th, 2021 • Genelux Corp • Pharmaceutical preparations • California
This Agreement/Promissory Note is entered into as of April 28, 2016. The parties to this Agreement are Jillian and Curtis Helmer (Lender) and Genelux Corporation (Borrower).
ContractGenelux Corp • June 24th, 2021 • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AS PROVIDED HEREIN AND IN A NOTE AND WARRANT PURCHASE AGREEMENT WITH THE COMPANY AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED HEREIN AND THEREIN, UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
